1.Nexium, Ospamox and Klacid (NOK) triple therapy for treatment of gastric ulcer with positive Helicobacter pylori
Journal of Medical and Pharmaceutical Information 2003;0(6):33-36
56 patients with gastric ulcers were treated by triple therapy with Nexium, Ospamox and Klacid (NOK).45 days after treatment, 89.3% patients had no gastric pain; 92.8% patients had ulcer healing, HP eradication rate 94.6% at 6 months and 12 months after treatment, 95% and 93.8% patients had ulcer healing; HP eradication rate was 90% and 90.6%; gastric pain and ulcer recurrence was 7.5% and 6.3%, respectively; HP-positive return rate was 10% and 9.4%
Stomach Ulcer, Helicobacter pylori, Therapeutics
2.Evaluation the effect of pantoprazole, amoxicillin and clarithromycin (PAC500) in the treatment of gastric and duodenal ulcer patients with H.pylori infection
Journal Ho Chi Minh Medical 2004;8(4):204-209
Therapeutics; Helicobacter pylori; Duodenal Ulcer; Stomach Ulcer; Pharmaceutical Preparations; 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin
Study on the effect of PAC500 regimen in the treatment of peptic ulcer disease with H. pylori (+) in 33 patients. The results showed that, this regimen is good with the mean value of pain relief is 6.5 days in addition to the high percentage of ulcer healing (96.9%: protocol and 93.9%: intention of treatment) and the high percentage of H.pylori eradication (87.5%: protocol and 84.8%: intention of treatment). Beside, there is an improvement of the acute gastritis lesion on gastric mucosa after the eradication. But the high percentage of side-effects (81.8%) must be considered, bitter sensation of the mouth is the most common and can be tolerated. Reported only 1 case had to withdraw this trial because of vomitting side-effect
Therapeutics
;
Helicobacter pylori
;
Duodenal Ulcer
;
Stomach Ulcer
;
Pharmaceutical Preparations
;
2-Pyridinylmethylsulfinylbenzimidazoles
;
Amoxicillin
;
Clarithromycin